Symbol Name ID |
Tlr4
toll-like receptor 4 MGI:96824 |
* | Aspects of the system are reported to show a normal phenotype. |
Darker colors indicate more annotations |
Human Phenotypes | Pedal edema |
Abnormality of metabolism/homeostasis |
Increased LDL cholesterol concentration |
Hypercholesterolemia |
Hypertriglyceridemia |
Elevated circulating C-reactive protein concentration |
Elevated circulating amyloid A concentration |
Elevated erythrocyte sedimentation rate |
Glucose intolerance |
Diabetes mellitus |
Type II diabetes mellitus |
Impaired glucose tolerance |
Insulin resistance |
Pleural effusion |
Fever |
Recurrent fever |
Food intolerance |
Hematuria |
Decreased level of D-mannose in urine |
Proteinuria |
Amyloidosis |
Renal amyloidosis |
Ascites |
Disease(s) Associated with TLR4 | |||||||||||||||||||||||
atopic dermatitis | |||||||||||||||||||||||
Behcet's disease | |||||||||||||||||||||||
coronary artery disease | |||||||||||||||||||||||
familial mediterranean fever | |||||||||||||||||||||||
temporal arteritis | |||||||||||||||||||||||
type 2 diabetes mellitus |
Mouse Phenotypes | homeostasis/metabolism phenotype |
decreased response of heart to induced stress |
abnormal vascular wound healing |
abnormal circulating glucose level |
decreased circulating insulin level |
abnormal circulating leptin level |
decreased circulating interleukin-6 level |
increased circulating interleukin-6 level |
abnormal circulating enzyme level |
decreased circulating alanine transaminase level |
decreased body temperature |
pulmonary edema |
abnormal gas homeostasis |
increased oxygen consumption |
decreased respiratory quotient |
abnormal glucose homeostasis |
improved glucose tolerance |
increased adiponectin level |
abnormal bile salt level |
abnormal lipid level |
abnormal fatty acids level |
decreased liver triglyceride level |
abnormal cytokine level |
abnormal interleukin level |
abnormal tumor necrosis factor level |
decreased incidence of tumors by chemical induction |
decreased susceptibility to ischemic brain injury |
decreased cerebral infarct size |
decreased susceptibility to kidney reperfusion injury |
decreased susceptibility to injury |
|
Availability | Mouse Genotype | ||||||||||||||||||||||||||||||
Tlr4Lps-d/Tlr4Lps-d | * | ||||||||||||||||||||||||||||||
Tlr4lps-del/Tlr4lps-del | |||||||||||||||||||||||||||||||
Tlr4tm1.1Djh/Tlr4tm1.1Djh | |||||||||||||||||||||||||||||||
Tlr4tm1Aki/Tlr4tm1Aki | |||||||||||||||||||||||||||||||
Tlr4tm1Djh/Tlr4tm1Djh Tg(Vil1-cre)997Gum/0 (conditional) |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 04/16/2024 MGI 6.23 |
|
|